1. This is now the Spring of offers and counter-offers with the prices for generic drug makers setting new highs. Yesterday the Teva (TEVA) $82 per share offer for Mylan MYL -2.33% (MYL) is sure to be raised and the Perrigo ’s (PRGO) rebuff of Mylan’s $205 per share offer will have similar considerations.
2. Every man, woman and child in the U.S. will eventually take a pill manufactured by the new entity if Teva is successful in its pursuit of Mylan
Hey, check out all the research scientist jobs. Post your resume today!
